Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

NCT06030037 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Trial withdrawn per PI directive

Conditions

PD-1 Refractory Advanced Melanoma

Interventions

BIOLOGICAL: Healthy Donor Fecal Microbiota Transplantation (hdFMT)
DRUG: Pembrolizumab
DRUG: Lenvatinib

Sponsor

Diwakar Davar

Collaborators

[object Object]
[object Object]